Popular Weight Loss Drugs Linked to Higher Risk of Osteoporosis
- 2 days ago
- 2 min read
Millions of Americans have turned to GLP-1 medications like Ozempic and Wegovy to shed pounds and improve cardiovascular health, but new research highlights a silent side effect. According to data presented at the American Academy of Orthopaedic Surgeons’ annual meeting, these popular drugs may carry significant unintended consequences for bone and joint health.
In a study analyzing the medical records of over 146,000 adults with obesity and Type 2 diabetes, researchers discovered that GLP-1 users face a 30% increased risk of osteoporosis compared to nonusers. Specifically, 4% of GLP-1 users developed the bone-weakening condition over a five-year period, compared to roughly 3% of those not taking the drugs. Furthermore, the risk of gout—a painful inflammatory arthritis—was 12% higher among users, and instances of osteomalacia (bone softening) occurred twice as often.
Dr. John Horneff, an associate professor of orthopedic surgery at the University of Pennsylvania and the study's lead author, attributes these risks to the dramatic lifestyle changes induced by the drugs. Because GLP-1s heavily suppress appetite, patients often consume fewer bone-protective nutrients like vitamin D and calcium.
Horneff also points to the sheer mechanics of rapid weight loss, comparing the phenomenon to astronauts losing bone density in a zero-gravity environment. "There’s nothing forcing their bones to kind of hold their weight anymore," Horneff explained, noting that a skeleton accustomed to supporting a larger frame loses density when that weight vanishes rapidly. Additionally, rapid weight loss can cause temporary spikes in uric acid, which explains the heightened risk of gout.
Despite these findings, medical professionals stress that patients should not panic or abandon their medications. The FDA already notes a potential increased risk of bone fractures in older adults and women on the label for semaglutide. Instead of halting prescriptions, doctors emphasize the importance of mitigating these risks through lifestyle adjustments.
Dr. Christopher McGowan, a gastroenterologist and weight loss clinic director, notes that combining GLP-1 treatments with structured, weight-bearing exercise can stimulate bone-forming cells and maintain bone mass. Providers are now urged to closely monitor bone health while guiding patients on proper protein intake and nutrition.
As McGowan concluded, "The takeaway isn’t fear. It’s refinement".
🔖 Sources
Keywords: Risk of Osteoporosis
Risk of Osteoporosis
Comments